Business Context and Reporting Period
Company: Galectin Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 10, 2016
Reporting Period: Three months ended March 31, 2016
This filing serves to announce the company's results of operations and financial condition for the first quarter of 2016. The detailed financial data is incorporated by reference from a press release dated May 10, 2016 (Exhibit 99.1), which is not included in the provided text.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the attached press release (Exhibit 99.1), which is not part of the input content.
Material Changes
The filing text does not provide specific data to compare current period results against prior comparable periods. Investors must refer to the attached press release for details on material changes in operations or financial condition.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The filing explicitly states that statements regarding future financial performance are forward-looking and involve risks and uncertainties.
- Safe Harbor: These statements are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
- Risk Factors: Management directs investors to the "Risk Factors" section of the Annual Report on Form 10-K for the fiscal year ended December 31, 2015, and subsequent SEC filings for a detailed description of risks.
- Performance Variance: Future performance could differ significantly from management's expectations or results implied in the press release.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for specific Q1 2016 financial figures (revenue, net loss, cash position).
- Compare Q1 2016 results with Q1 2015 data to assess year-over-year trends.
- Consult the Form 10-K for the year ended December 31, 2015, for a comprehensive list of risk factors.
- Verify the company's cash runway and burn rate based on the detailed financial statements in the press release.